Search research articles
Contact Us
Filters
Showing results (131-140 of 170) with videos related to
Page
of 17
Sort By:
JCO Precision Oncology
|
July 27, 2023
Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer
Charu Aggarwal, Melina E Marmarelis, Wei-Ting Hwang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 24, 2023
Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation
Nikhil Yegya-Raman, Cole Friedes, Sang Ho Lee, et al.
Head & Neck
|
June 25, 2021
Survival and toxicity in patients with human papilloma virus-associated oropharyngeal squamous cell cancer receiving trimodality therapy including transoral robotic surgery
Lova Sun, David Shimunov, Erik X Tan, et al.
JCO Oncology Practice
|
June 27, 2025
International Medical Graduates Representation at International Oncology Conference Meetings: An Analysis of ASCO Annual Meetings
Arya Mariam Roy, Ziad Bakouny, Nazli Dizman, et al.
JCO Global Oncology
|
January 23, 2025
Precision Oncology: A Global Perspective on Implementation and Policy Development
Denis Horgan, Marcel Tanner, Charu Aggarwal, et al.
Clinical Lung Cancer
|
April 16, 2026
Use of an Integrative Genomics Approach to Identify Metastatic NSCLC Patients Benefiting From the Addition of Chemotherapy to Immune Checkpoint Inhibitors
Mark Klein, Drew Watson, Michael Castro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 13, 2023
Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations
Michael J Grant, Jacqueline V Aredo, Jacqueline H Starrett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2025
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: A Lung-MAP Study
Philip C Mack, Mary W Redman, Hanna Tukachinsky, et al.
JCO Precision Oncology
|
June 7, 2021
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy
Jeffrey C Thompson, Erica L Carpenter, Benjamin A Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 23, 2018
Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer
Charu Aggarwal, Roger B Cohen, Matthew P Morrow, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 170) with videos related to
Sort By:
Page
of 17
JCO Precision Oncology
|
July 27, 2023
Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer
Charu Aggarwal, Melina E Marmarelis, Wei-Ting Hwang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 24, 2023
Pneumonitis Rates Before and After Adoption of Immunotherapy Consolidation in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation
Nikhil Yegya-Raman, Cole Friedes, Sang Ho Lee, et al.
Head & Neck
|
June 25, 2021
Survival and toxicity in patients with human papilloma virus-associated oropharyngeal squamous cell cancer receiving trimodality therapy including transoral robotic surgery
Lova Sun, David Shimunov, Erik X Tan, et al.
JCO Oncology Practice
|
June 27, 2025
International Medical Graduates Representation at International Oncology Conference Meetings: An Analysis of ASCO Annual Meetings
Arya Mariam Roy, Ziad Bakouny, Nazli Dizman, et al.
JCO Global Oncology
|
January 23, 2025
Precision Oncology: A Global Perspective on Implementation and Policy Development
Denis Horgan, Marcel Tanner, Charu Aggarwal, et al.
Clinical Lung Cancer
|
April 16, 2026
Use of an Integrative Genomics Approach to Identify Metastatic NSCLC Patients Benefiting From the Addition of Chemotherapy to Immune Checkpoint Inhibitors
Mark Klein, Drew Watson, Michael Castro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 13, 2023
Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations
Michael J Grant, Jacqueline V Aredo, Jacqueline H Starrett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2025
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: A Lung-MAP Study
Philip C Mack, Mary W Redman, Hanna Tukachinsky, et al.
JCO Precision Oncology
|
June 7, 2021
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy
Jeffrey C Thompson, Erica L Carpenter, Benjamin A Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 23, 2018
Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer
Charu Aggarwal, Roger B Cohen, Matthew P Morrow, et al.
Page
of 17